|
BNTC Benitec Biopharma Inc 1808898 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-11,935,000.00 |
| Balance Sheet |
|
Current Assets
|
$186,017,000.00 |
|
Assets
|
$187,000,000.00 |
|
Current Liabilities
|
$3,274,000.00 |
|
Liabilities
|
$3,668,000.00 |
|
Equity
|
$183,332,000.00 |
|
Shares Out
|
34354334.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-11,579,000.00 |
|
Investing Cash Flow
|
$-26,000.00 |
| Market Analysis |
Market Cap
|
$407,442,401.24 |
|
Price
|
$11.96 |
|
BVPS
|
5.34 |
|
PB
|
2.22 |
|
EPS
|
-0.24 |
|
FCF
|
$-11,605,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:27 |
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-12 |
-0.26 |
| Apr |
May |
Jun |
|
|
|
|
2026-05-14 |
-0.24 |
| Oct |
Nov |
Dec |
| 2025-09-22 |
|
|
|
2025-11-14 |
-0.22 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BNTC documents filed with the SEC.
BNTC Filings
Clear